0000000000052899

AUTHOR

Simone Müschenborn

showing 2 related works from this author

Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant…

1998

With an increasing number of new vaccines available for routine childhood immunization, combination vaccines are needed in order to maintain or achieve a high compliance with recommended immunization programmes. In a prospective, randomized, comparative, multi-centre study, 822 healthy infants were enrolled to receive three doses of either a candidate or a commercially available Haemophilus influenzae type b (Hib) vaccine concomitantly with diphtheria-, tetanus- acellular pertussis (DTaP) vaccine. Study subjects were randomly allocated to one of the following groups: (1) separate, or (2) mixed injection of DTaP and candidate Hib vaccine, or (3) separate injection of DTaP and commercial Hib …

MaleHaemophilus InfectionsWhooping CoughImmunization SecondaryEnzyme-Linked Immunosorbent AssayBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinescomplex mixturesTetanus ToxoidmedicineHumansProspective StudiesDiphtheria-Tetanus-Pertussis VaccineDiphtheria-Tetanus-acellular Pertussis VaccinesWhooping coughHaemophilus VaccinesAnalysis of VarianceChi-Square DistributionTetanusVaccines ConjugateReactogenicityTetanusbusiness.industryDiphtheriaToxoidInfantDiphtheriamedicine.diseaseAntibodies BacterialHib vaccinePediatrics Perinatology and Child HealthImmunologyFemalebusinessEuropean Journal of Pediatrics
researchProduct

Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization a…

1996

Abstract Objectives: To compare the immunogenicities and reactogenicities of bicomponent (B) (pertussis toxoid, filamentous hemagglutinin) and tricomponent (T) (pertussis toxoid, filamentous hemagglutinin, pertactin) acellular pertussis vaccines when coadministered with diphtheria and tetanus toxoids in primary (3, 4, and 5 mo) and booster (15–19 mo) vaccinations. Design and Methods: A randomized, double-blind study involving 175 children aged 12 to 18 weeks. Reactogenicity was based on diary cards, immunogenicity assessed by ELISA measurements of serum IgG antibodies. Results: There were no clinically relevant differences in local (B = 34.5; T=31.3%) and general (B = 43.9; T=41.8%) reactog…

Microbiology (medical)ReactogenicityTetanusbusiness.industrypertussisDiphtheriaToxoidFilamentous haemagglutinin adhesinGeneral MedicineBooster dosetoxoidmedicine.diseasecomplex mixturesVirologypertactinVaccinationacellular hemagglutininInfectious DiseasesImmunologymedicinePertactinbusinessInternational Journal of Infectious Diseases
researchProduct